Geranylgeranyl Pyrophosphate Promotes Profibrotic Factors and Collagen-Specific Chaperone HSP47 in Fibroblasts.

Area of Science:

• Biochemistry
• Cell Biology
• Pathology

Background:

• Fibrosis, marked by excessive extracellular matrix deposition, leads to organ failure and mortality.
• Fibroblast activation into myofibroblasts involves phenotypic changes like increased α-smooth muscle actin (α-SMA), periostin, FAP, and HSP47.
• The precise cellular mechanisms driving fibroblast trans-differentiation in fibrosis remain unclear.

Purpose of the Study:

• To investigate the role of geranylgeranyl pyrophosphate (GGPP) signaling in regulating profibrotic mechanisms.
• To determine if GGPP is essential for fibroblast-to-myofibroblast activation.

Main Methods:

• Pharmacological inhibition of geranylgeranyl pyrophosphate synthase (GGPS1).
• Assessment of myofibroblast differentiation markers (α-SMA, periostin, FAP, HSP47) following GGPS1 inhibition.
• Restoration of differentiation with exogenous GGPP and selective inhibition of prenyl transferases.

Main Results:

• GGPS1 inhibition significantly decreased TGF-β1-induced myofibroblast differentiation markers.
• Exogenous GGPP rescued TGF-β1-induced differentiation under GGPS1 inhibition.
• Selective inhibition of geranylgeranyl or farnesyl transferase impacted α-SMA and HSP47 expression.
• HSP47 inhibition suppressed TGF-β1-induced α-SMA expression, but this was not rescued by GGPP.

Conclusions:

• GGPP-dependent pathways, independent of cholesterol synthesis, play a functional role in fibroblast-to-myofibroblast transition.
• Protein prenylation is a key regulator of myofibroblast differentiation.
• Targeting GGPP signaling presents a novel therapeutic strategy for antifibrosis therapies.